Tulasee Bio-Ethanol Limited submitted its unaudited standalone financial results for the quarter ended June 30, 2026, to the Bombay Stock Exchange. The results were approved by the Board of Directors at their meeting held on August 7, 2026, at 3:00 PM, which concluded at 3:30 PM.

Financial Performance (Quarter Ended June 30, 2026)

  • Revenue from Operations: ₹0.00 lakh
  • Other Income: ₹0.00 lakh
  • Total Revenue: ₹0.00 lakh
  • Total Expenses: ₹6.42 lakh
  • Cost of materials consumed: ₹0.00 lakh
  • Purchases of stock-in-trade: ₹0.00 lakh
  • Changes in inventories: ₹0.00 lakh
  • Employee benefits expense: ₹0.00 lakh
  • Finance costs: ₹0.00 lakh
  • Depreciation and amortization expense: ₹0.00 lakh
  • Other expenses: ₹6.42 lakh
  • Loss before tax: ₹(6.42) lakh
  • Tax Expense: ₹0.00 lakh
  • Current tax: ₹0.00 lakh
  • Deferred tax: ₹0.00 lakh
  • Net Loss for the period: ₹(6.42) lakh
  • Earnings per share (Basic and Diluted): ₹(0.11)

Comparative Financials

Quarter Ended June 30, 2026 (Unaudited) vs Year Ended March 31, 2026 (Audited):

  • Net loss after tax: ₹(6.42) lakh (Q1 FY27) vs ₹(17.94) lakh (FY26)
  • No exceptional items or discontinued operations in either period

Balance Sheet Highlights (as of June 30, 2026)

Assets:

  • Non-current assets: ₹485.92 lakh
  • Property, plant and equipment: ₹467.18 lakh
  • Non-current investments: ₹0.20 lakh
  • Other non-current assets: ₹18.54 lakh
  • Current assets: ₹356.86 lakh
  • Inventories: ₹21.21 lakh
  • Cash and cash equivalents: ₹0.75 lakh
  • Loans (current): ₹241.41 lakh
  • Current tax assets: ₹93.49 lakh

Equity and Liabilities:

  • Equity: ₹45.46 lakh
  • Equity share capital: ₹583.78 lakh
  • Other equity: ₹(538.32) lakh
  • Non-current liabilities: ₹764.81 lakh
  • Non-current financial liabilities (borrowings): ₹764.81 lakh
  • Current liabilities: ₹32.51 lakh
  • Trade payables: ₹24.20 lakh
  • Other current liabilities: ₹8.32 lakh

Cash Flow Statement (Year Ended June 30, 2026)

  • Net cash from operating activities: ₹(12,458)
  • Net cash from investing activities: ₹0
  • Net cash from financing activities: ₹2,500
  • Net decrease in cash and cash equivalents: ₹(9,958)
  • Opening balance of cash and cash equivalents: ₹85,446
  • Closing balance of cash and cash equivalents: ₹75,488

Regulatory Compliance and Standards

The financial results have been:

  • Reviewed by the Audit Committee
  • Approved by the Board of Directors on August 7, 2026
  • Reviewed by the statutory auditors, A. C. Jhaveri & Associates
  • Prepared in accordance with Indian Accounting Standards (Ind AS 34)
  • Submitted pursuant to Regulation 33 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
  • The company adopted Ind AS from April 1, 2017

The limited review report by A. C. Jhaveri & Associates (Registration No.: 137685W) states that nothing has come to their attention that causes them to believe the financial results contain any material misstatement. The review was conducted in accordance with Standard on Review Engagement (SRE) 2410.